Skip to main content
logo
Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.950
+0.030 (1.03%)
Sep 3, 2026, 4:00 PM EDT - Market closed

Entera Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.040.18-0.130.57
Revenue Growth
--76.80%---76.53%56.44%
Gross Profit
--0.01-0.030.2
Operating Income
-14.4-11.53-9.59-8.89-13.47-12.22
Net Income
-17.03-11.44-9.54-8.89-13.07-12.19
Earnings Per Share
-0.35-0.25-0.25-0.31-0.45-0.47
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
11.317.118.6611.0212.3124.89
Total Debt
0.430.490.270.390.090.3
Net Cash (Debt)
10.886.628.3910.6312.2224.59
Net Cash Growth
2.15%-21.10%-21.08%-13.00%-50.31%201.31%
Net Cash Per Share
0.230.140.220.370.420.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.89-7.37-6.82-7.31-12.5-9.06
Capital Expenditures
-0.07-0.11-0-0.02-0.05-0.02
Free Cash Flow
-10.96-7.48-6.82-7.33-12.55-9.08
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--4.97%-24.63%34.68%
Operating Margin
--27450.00%-5295.58%--10055.22%-2139.58%
Pretax Margin
--27235.71%-5263.54%--9652.24%-2144.66%
Profit Margin
--27235.71%-5271.27%--9754.48%-2134.33%
FCF Margin
--17802.38%-3768.51%--9362.69%-1590.19%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-2118.17431.41-156.95141.91